Cognoa is a behavioral health company.
Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics to enable the earlier diagnosis and treatment of behavioral health conditions, such as autism. Its ai technology platform will enable the product pipeline to address additional unmet needs including adhd and anxiety. It is focused on improving the lives and outcomes of children and families living with behavioral conditions.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 14, 2022 | Series B | $73.10M | — | — | — | Detail |
Oct 31, 2019 | Series A | — | 1 | — | — | Detail |
Oct 27, 2019 | Series A | $45.07M | 1 | Morningside Venture Investments | — | Detail |
Oct 31, 2016 | Series A | $3.82M | 1 | Morningside Group | — | Detail |
Aug 28, 2013 | Series A | $5M | 1 | Morningside Group | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Morningside Venture Investments | Yes | Series A |
Morningside Group | Yes | Series A |
Stanford Technology Ventures Program | — | Series A |